| 1 |
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
Jan M.M. Walboomers, Marcel V. Jacobs, M. Michele Manos et al. · The Journal of Pathology
Open access |
Sep 1999 |
9,115 |
| 2 |
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al. · The Lancet Oncology
|
10 Mar 2009 |
7,889 |
| 3 |
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
Núbia Muñóz, Francesc Xavier Bosch, Sílvia de Sanjosé et al. · New England Journal of Medicine
Open access |
5 Feb 2003 |
6,330 |
| 4 |
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Edward B. Garon et al. · New England Journal of Medicine
Open access |
19 Apr 2015 |
6,312 |
| 5 |
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell et al. · The Lancet Oncology
Open access |
30 Jan 2012 |
5,563 |
| 6 |
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
Madan Jagasia et al. · Transplantation and Cellular Therapy
Open access |
19 Dec 2014 |
5,493 |
| 7 |
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al. · Nature Medicine
Open access |
12 Oct 2015 |
5,415 |
| 8 |
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
Jan B. Vermorken, Ricard Mesı́a, Fernando Rivera et al. · New England Journal of Medicine
Open access |
10 Sep 2008 |
3,762 |
| 9 |
The causal relation between human papillomavirus and cervical cancer
Francesc Xavier Bosch, Attila Tibor Lorincz, N Munoz et al. · Journal of Clinical Pathology
Open access |
Apr 2002 |
3,609 |
| 10 |
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Eric Van Cutsem et al. · Annals of Oncology
Open access |
5 Jul 2016 |
3,512 |
| 11 |
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
Francesc Xavier Bosch, M. Michele Manos, N. Munoz et al. · JNCI Journal of the National Cancer Institute
|
7 Jun 1995 |
3,439 |
| 12 |
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Ann Burtness et al. · The Lancet
Open access219 authors |
Nov 2019 |
3,344 |
| 13 |
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Javier A. Menéndez, Ruth Lupu · Nature reviews. Cancer
Review |
20 Sep 2007 |
3,020 |
| 14 |
Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
Matthew David Hellmann et al. · New England Journal of Medicine
Open access |
28 Sep 2019 |
2,901 |
| 15 |
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan et al. · New England Journal of Medicine
Open access |
10 Dec 2012 |
2,827 |
| 16 |
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjosé et al. · The Lancet Oncology
|
18 Oct 2010 |
2,774 |
| 17 |
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Shanu Modi et al. · New England Journal of Medicine
Open access |
5 Jun 2022 |
2,702 |
| 18 |
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi et al. · New England Journal of Medicine
Open access |
24 Feb 2021 |
2,554 |
| 19 |
Alectinib versus Crizotinib in Untreated ALK -Positive Non–Small-Cell Lung Cancer
Solange Peters, D. Ross Camidge, Alice Tsang Shaw et al. · New England Journal of Medicine
Open access |
6 Jun 2017 |
2,523 |
| 20 |
Primary liver cancer: Worldwide incidence and trends
Francesc Xavier Bosch, Josepa Ribes, Mireia Díaz et al. · Gastroenterology
|
Nov 2004 |
2,507 |
| 21 |
International network of cancer genome projects
Jennifer L. Jennings et al. · Nature
Open access256 authors |
13 Apr 2010 |
2,439 |
| 22 |
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
Rafael Rosell et al. · New England Journal of Medicine
Open access |
19 Aug 2009 |
2,388 |
| 23 |
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Pàez‐Ribes, Elizabeth Allen, James Hudock et al. · Cancer Cell
Open access |
Mar 2009 |
2,355 |
| 24 |
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Antonio González-Martı́n et al. · New England Journal of Medicine
Open access |
28 Sep 2019 |
2,318 |
| 25 |
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad, Chong Sun, Sidong Huang et al. · Nature
Open access |
26 Jan 2012 |
2,092 |
| 26 |
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Michael Weller et al. · Nature Reviews Clinical Oncology
ReviewOpen access |
8 Dec 2020 |
2,063 |
| 27 |
SNPStats: a web tool for the analysis of association studies
Xavier Solé, Elisabet Guinó, Joan Valls et al. · Bioinformatics
Open access |
23 May 2006 |
2,058 |
| 28 |
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection
Elio Ríboli et al. · Public Health Nutrition
Open access |
Dec 2002 |
1,906 |
| 29 |
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Manuel M. Hidalgo, Frédéric Amant, Andrew Victor Biankin et al. · Cancer Discovery
Open access |
16 Jul 2014 |
1,810 |
| 30 |
Gastroenteropancreatic neuroendocrine tumours
Irvin Mark Modlin, Kjell Öberg, Daniel C. Chung et al. · The Lancet Oncology
|
2008 |
1,768 |
| 31 |
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
Jan Baptist Vermorken, Éva Remenár, Carla van Herpen et al. · New England Journal of Medicine
Open access |
24 Oct 2007 |
1,726 |
| 32 |
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
Silvia de Sanjosé, Mireia Díaz, Xavier Castellsagué et al. · The Lancet Infectious Diseases
Review |
26 Jun 2007 |
1,693 |
| 33 |
Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings
Laia Bruni, Mireia Díaz, Xavier Castellsagué et al. · The Journal of Infectious Diseases
|
10 Nov 2010 |
1,666 |
| 34 |
Global Burden of Human Papillomavirus and Related Diseases
David Forman, Catherine de Martel, Charles J. Lacey et al. · Vaccine
Open access |
Nov 2012 |
1,664 |
| 35 |
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
Jorma A. Paavonen et al. · The Lancet
|
Jul 2009 |
1,663 |
| 36 |
Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Hagop M. Kantarjian, Neil P. Shah, Andreas Hochhaus et al. · New England Journal of Medicine
|
5 Jun 2010 |
1,601 |
| 37 |
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
Jean‐Yves Douillard et al. · The Lancet Oncology
|
18 Aug 2006 |
1,600 |
| 38 |
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis
Sónia A. Melo, Hikaru Sugimoto, Joyce T. O’Connell et al. · Cancer Cell
Open access |
24 Oct 2014 |
1,590 |
| 39 |
The Biology and Life-Cycle of Human Papillomaviruses
John Doorbar, Wim G.V. Quint, Lawrence Banks et al. · Vaccine
|
Nov 2012 |
1,556 |
| 40 |
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xosé S. Puente et al. · Nature
Open access |
3 Jun 2011 |
1,531 |
| 41 |
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
Meletios Athanasios Dimopoulos et al. · New England Journal of Medicine
Open access |
5 Oct 2016 |
1,454 |
| 42 |
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Guillem Argilés, Josep M. Tabernero, Roberto Labianca et al. · Annals of Oncology
Open access |
20 Jul 2020 |
1,399 |
| 43 |
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
J. Mazieres et al. · Annals of Oncology
Open access |
15 May 2019 |
1,390 |
| 44 |
Chapter 1: HPV in the etiology of human cancer
Nubia Muñóz, Xavier Castellsagué, Amy Berrington de González et al. · Vaccine
|
24 Jun 2006 |
1,369 |
| 45 |
Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
A. Keith Stewart et al. · New England Journal of Medicine
Open access |
6 Dec 2014 |
1,342 |
| 46 |
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
Jorma A. Paavonen et al. · The Lancet
|
Jun 2007 |
1,320 |
| 47 |
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
Rayjean J. Hung et al. · Nature
Open access |
Apr 2008 |
1,296 |
| 48 |
Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium
Mia Hashibe et al. · Cancer Epidemiology Biomarkers & Prevention
Open access |
Feb 2009 |
1,270 |
| 49 |
Teclistamab in Relapsed or Refractory Multiple Myeloma
Philippe Moreau et al. · New England Journal of Medicine
Open access |
5 Jun 2022 |
1,239 |
| 50 |
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang et al. · Nature Genetics
Open access |
Jul 2012 |
1,238 |